M
MaxCyte, Inc. (MXCT)
NMS – Real Time Price. Currency in USD
0.82
+0.01 (0.65%)
At close: May 12, 2026, 4:00 PM EDT
0.88
+0.06 (7.41%)
Pre-market: May 13, 2026, 4:01 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
0.82
+0.01 (0.65%)
At close: May 12, 2026, 4:00 PM EDT
0.88
+0.06 (7.41%)
Pre-market: May 13, 2026, 4:01 AM EDT
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
| Name | Position |
|---|---|
| Mr. Jack Horgan | Senior Vice President of Corporate Development |
| Mr. Jay Gelfman | Chief Operations Officer |
| Mr. Maher Masoud | President, CEO & Executive Director |
| Mr. Parmeet Ahuja | Chief Financial Officer |
| Ms. Ana-Paula Martins Fernandes | Senior Vice President of Global Sales |
| Ms. Jill Mayer | Senior Vice President of Human Resources |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | DEFA14A | ny20071620x2_defa14a.htm |
| 2026-04-15 | S-8 | tm2611297d1_s8.htm |
| 2026-03-27 | 8-K | mxct-20260323x8k.htm |
| 2026-03-25 | 10-K | mxct-20251231x10k.htm |
| 2026-03-24 | 8-K | mxct-20260324x8k.htm |
| 2026-03-20 | 8-K | mxct-20260316x8k.htm |
| 2026-01-12 | 8-K | mxct-20260112x8k.htm |
| 2025-11-13 | 10-Q | mxct-20250930x10q.htm |
| 2025-11-12 | 8-K | mxct-20251112x8k.htm |
| 2025-11-05 | 8-K | mxct-20251105x8k.htm |